Yu Jin Shin

866 total citations
30 papers, 699 citations indexed

About

Yu Jin Shin is a scholar working on Molecular Biology, Biomedical Engineering and Pathology and Forensic Medicine. According to data from OpenAlex, Yu Jin Shin has authored 30 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Biomedical Engineering and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Yu Jin Shin's work include Bioactive Compounds and Antitumor Agents (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Advanced Sensor and Energy Harvesting Materials (3 papers). Yu Jin Shin is often cited by papers focused on Bioactive Compounds and Antitumor Agents (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Advanced Sensor and Energy Harvesting Materials (3 papers). Yu Jin Shin collaborates with scholars based in South Korea, United States and Thailand. Yu Jin Shin's co-authors include Cheolmin Park, Youn Jung Park, Seok Ju Kang, Insung Bae, Hyung Sik Kim, Byung Mu Lee, Tae Hyung Kim, A Jin Won, Ho‐Cheol Kim and June Huh and has published in prestigious journals such as Advanced Materials, Nano Letters and Advanced Functional Materials.

In The Last Decade

Yu Jin Shin

27 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Jin Shin South Korea 15 227 175 173 124 101 30 699
Kang Tang China 19 116 0.5× 229 1.3× 192 1.1× 99 0.8× 50 0.5× 51 1000
Jinxiu Li China 15 70 0.3× 292 1.7× 164 0.9× 123 1.0× 33 0.3× 41 979
Jialiu Zeng United States 19 126 0.6× 306 1.7× 284 1.6× 108 0.9× 36 0.4× 32 1.1k
Rita Maalouf Lebanon 13 269 1.2× 410 2.3× 228 1.3× 87 0.7× 55 0.5× 21 1.1k
Jingxian Wang China 17 47 0.2× 142 0.8× 220 1.3× 87 0.7× 66 0.7× 59 787
Fozia Shaheen Pakistan 21 152 0.7× 125 0.7× 226 1.3× 318 2.6× 119 1.2× 51 1.1k
Xiaoxue Bai China 19 116 0.5× 572 3.3× 253 1.5× 145 1.2× 74 0.7× 39 1.0k
Xianghua Han China 16 73 0.3× 228 1.3× 108 0.6× 296 2.4× 33 0.3× 31 1.1k

Countries citing papers authored by Yu Jin Shin

Since Specialization
Citations

This map shows the geographic impact of Yu Jin Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Jin Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Jin Shin more than expected).

Fields of papers citing papers by Yu Jin Shin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Jin Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Jin Shin. The network helps show where Yu Jin Shin may publish in the future.

Co-authorship network of co-authors of Yu Jin Shin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Jin Shin. A scholar is included among the top collaborators of Yu Jin Shin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Jin Shin. Yu Jin Shin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Hae-In, Heejin Jun, Joo‐Young Kim, et al.. (2025). Targeting RBM39 with Tasisulam enhances TRAIL-induced apoptosis through DR5 upregulation and Bcl-2 downregulation in renal cell carcinoma. Biochemical Pharmacology. 236. 116877–116877.
3.
Yoo, Ran Ji, Ji Yong Park, Ji Yoon Kim, et al.. (2024). Development of finely tuned liposome nanoplatform for macrophage depletion. Journal of Nanobiotechnology. 22(1). 83–83. 11 indexed citations
4.
Ryu, Yea Seong, Yu Jin Shin, Jeong Hee Kim, et al.. (2023). Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer. Cancer Biology & Therapy. 24(1). 2246208–2246208. 3 indexed citations
5.
Shin, Yu Jin, et al.. (2023). Uric acid regulates α-synuclein transmission in Parkinsonian models. Frontiers in Aging Neuroscience. 15. 1117491–1117491. 3 indexed citations
6.
Shin, Jin Young, et al.. (2022). Priming mesenchymal stem cells with α-synuclein enhances neuroprotective properties through induction of autophagy in Parkinsonian models. Stem Cell Research & Therapy. 13(1). 483–483. 20 indexed citations
7.
Ahn, SoEun, Wooyeong Joo, Yu Jin Shin, et al.. (2020). Development of Korea National Ecosystem Assessment Framework to Support Decision Making. Journal of Environmental Policy and Administration. 28(2). 101–129. 1 indexed citations
8.
Shin, Yu Jin, Raimundo Ho, Ahmad Y. Sheikh, et al.. (2019). Toward a Holistic Approach To Assess Particle Agglomeration: Impact of Intrinsic Materials Properties. Industrial & Engineering Chemistry Research. 58(24). 10394–10401. 5 indexed citations
9.
Shin, Yu Jin, et al.. (2018). Anti-Tumor Activity of Procyanidin and Its Effect on Hemocytes and Immunity. Journal of the Korean Society of Food Science and Nutrition. 47(10). 966–972. 2 indexed citations
10.
Shin, Yu Jin, Jeong Hee Kim, Jai-Hee Moon, et al.. (2016). Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells. Toxicology Letters. 258. 126–133. 24 indexed citations
11.
Lee, Dae‐Hee, Jai-Hee Moon, Seung-Woo Hong, et al.. (2016). L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells. Free Radical Biology and Medicine. 95. 200–208. 38 indexed citations
12.
Park, Seongjoon, Jeong Hee Kim, Yu Jin Shin, et al.. (2015). SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin. Tumor Biology. 37(4). 4323–4330. 16 indexed citations
13.
Shin, Yu Jin, Jeong Jun Kim, Ye Ji Kim, et al.. (2015). Protective Effects of Quercetin Against HgCl 2 -Induced Nephrotoxicity in Sprague-Dawley Rats. Journal of Medicinal Food. 18(5). 524–534. 21 indexed citations
14.
Shin, Yu Jin, Tae Hyung Kim, A Jin Won, et al.. (2014). Age-related differences in kidney injury biomarkers induced by cisplatin. Environmental Toxicology and Pharmacology. 37(3). 1028–1039. 13 indexed citations
15.
Kim, Tae Hyung, Yu Jin Shin, A Jin Won, et al.. (2013). Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Biochimica et Biophysica Acta (BBA) - General Subjects. 1840(1). 615–625. 123 indexed citations
16.
Shin, Yu Jin, Emilie Ringe, Michelle L. Personick, et al.. (2013). Centrifugal Shape Sorting and Optical Response of Polyhedral Gold Nanoparticles. Advanced Materials. 25(29). 4023–4027. 17 indexed citations
17.
Lee, Ki Yong, Yu Jin Shin, Dong H. Kim, et al.. (2013). Micelle-Mediated Extraction of Dibenzocyclooctadiene Lignans from Schisandra chinensis with Analysis by High-Performance Liquid Chromatography. Journal of Chromatographic Science. 52(7). 745–750. 5 indexed citations
18.
Kim, Tae Hyung, Mee Young Ahn, Young Ju Lee, et al.. (2012). Evaluation of metabolomic profiling against renal toxicity in Sprague–Dawley rats treated with melamine and cyanuric acid. Archives of Toxicology. 86(12). 1885–1897. 19 indexed citations
19.
Kang, Seok Ju, Insung Bae, Yu Jin Shin, et al.. (2010). Nonvolatile Polymer Memory with Nanoconfinement of Ferroelectric Crystals. Nano Letters. 11(1). 138–144. 126 indexed citations
20.
Jung, Hee Joon, Yu Jin Shin, Youn Jung Park, et al.. (2010). Ultrathin, Organic, Semiconductor/Polymer Blends by Scanning Corona‐Discharge Coating for High‐Performance Organic Thin‐Film Transistors. Advanced Functional Materials. 20(17). 2903–2910. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026